About this trial
Short-term comparison of clinical application effects of Astra OsseoSpeed EV short implants and conventional implants for maxillary sinus elevation
Eligibility criteria
Qualifiers
Patients aged over 18 years old with at least one area of the posterior dental arch having insufficient alveolar bone height (3-6 mm)
Patients are in good health and have no major systemic diseases such as diabetes or cardiovascular diseases, and no maxillary sinus lesions
They are willing to undergo implant restoration treatment and can complete at least 3-year follow-up.
Disqualifiers
horizontal bone deficiency alveolar ridges,bone defects caused by tumor resection
excessive tobacco use (more than 10 cigarettes per day)
severe liver and kidney diseases
history of radiotherapy and chemotherapy in the head and neck region
Trial design
Treatments tested in this trial
- short implants (L=6.3mm)
- short implants (L=8mm)
- conventional implants (L=9mm)
Treatment groups
Sponsors and collaborators
Linhu Wang
Lead sponsor
Wuhan Central Hospital
Sponsor institution
Dentsply Sirona Implants and Consumables
Collaborator